Is BIOPX or CL a better dividend investment in 2026?

BIOPX currently yields 4.65% with a 5% 5-year dividend growth rate. CL yields 4.00% with 5% growth. The better choice depends on your goal: BIOPX offers higher current income.

What is the dividend yield difference between BIOPX and CL?

BIOPX has a forward dividend yield of 4.65% ($2.29/share annually). CL yields 4.00% ($2.00/share annually). The yield gap is 0.65 percentage points.

Home › Compare › BIOPX vs CL

BIOPX vs CL: Dividend Comparison 2026

BIOPX yields 4.65% · CL yields 4.00%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CL wins by $921.00 in total portfolio value· pulled ahead in Year 6

INVESTMENT

TIME HORIZON10 years

BIOPX

● Live price

4.65%

Share price

$49.16

Annual div

$2.29

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$27.1K

Annual income

$626.70

Full BIOPX calculator →

● Live price

4.00%

Share price

$50.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$28.0K

Annual income

$899.19

Full CL calculator →

Portfolio growth — BIOPX vs CL

📍 CL pulled ahead of the other in Year 6

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	BIOPX	CL
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, BIOPX + CL cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

BIOPX pays

CL pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BIOPX

Annual income on $10K today (after 15% tax)

$395.43/yr

After 10yr DRIP, annual income (after tax)

$532.70/yr

Annual income on $10K today (after 15% tax)

$340.00/yr

After 10yr DRIP, annual income (after tax)

$764.31/yr

At 15% tax rate, CL beats the other by $231.62/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BIOPX + CL for your $10,000?

BIOPX: 50%CL: 50%

100% CL50/50100% BIOPX

Portfolio after 10yr

$27.6K

Annual income

$762.95/yr

Blended yield

2.77%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on CL right now

BIOPX

No analyst data

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Price Target

$92.45

+84.9% upside vs current

Range: $85.00 — $100.00

Altman Z

4.5

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BIOPX buys

CL buys

Politician	Chamber	Ticker	Type	Amount	Date
John Boozman	🏛 Senate	$CL	▼ Sell	$1,001 - $15,000	2025-10-09
Ro Khanna	🏢 House	$CL	▼ Sell	$1,001 - $15,000	2025-10-07
Rick Larsen	🏢 House	$CL	▼ Sell	$1,001 - $15,000	2025-10-06
Ro Khanna	🏢 House	$CL	▼ Sell	$1,001 - $15,000	2025-09-29
Julie Johnson	🏢 House	$CL	▼ Sell	$1,001 - $15,000	2025-09-25
Lisa McClain	🏢 House	$CL	▼ Sell	$1,001 - $15,000	2025-09-11
Tim Moore	🏢 House	$CL	▼ Sell	$1,001 - $15,000	2025-09-10
Ro Khanna	🏢 House	$CL	▲ Buy	$1,001 - $15,000	2025-09-05
Ro Khanna	🏢 House	$CL	▲ Buy	$1,001 - $15,000	2025-08-26
Lisa McClain	🏢 House	$CL	▲ Buy	$1,001 - $15,000	2025-08-13

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricBIOPXCL

Forward yield	4.65% ✓	4.00%
Annual dividend / share	$2.29 ✓	$2.00
Payout ratio	50%	50%
1-year div growth	0%	5% ✓
5-year div CAGR	0%	5% ✓
Portfolio after 10y	$27.1K	$28.0K ✓
Annual income after 10y	$626.70	$899.19 ✓
Total dividends collected	$5.5K	$6.4K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Consumer Staples

Year-by-year: BIOPX vs CL ($10,000, DRIP)

Year	BIOPX Portfolio	BIOPX Income/yr	CL Portfolio	CL Income/yr	Gap
1	$11,165	$465.22	$11,120	$420.00	+$45.00 → BIOPX
2	$12,432	$485.44	$12,357	$458.31	+$75.00 → BIOPX
3	$13,808	$505.17	$13,721	$499.76	+$87.00 → BIOPX
4	$15,299	$524.35	$15,227	$544.58	+$72.00 → BIOPX
5	$16,912	$542.96	$16,885	$593.02	+$27.00 → BIOPX
6← crossover	$18,657	$560.97	$18,713	$645.34	$56.00 → CL
7	$20,542	$578.36	$20,724	$701.81	$182.00 → CL
8	$22,575	$595.12	$22,938	$762.73	$363.00 → CL
9	$24,766	$611.23	$25,372	$828.41	$606.00 → CL
10	$27,126	$626.70	$28,047	$899.19	$921.00 → CL

BIOPX vs CL: Complete Analysis 2026

BIOPX — Stock

The fund invests primarily in equity securities in the form of common stock of U.S. high growth businesses of any market capitalization selected for their capital appreciation potential. The Adviser may invest in companies in any sector or industry that the adviser believes will benefit from innovations and advances in technology.

Full BIOPX Calculator →

CL — Consumer Staples

CL is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in CL shares.

Full CL Calculator →

📬

Get this BIOPX vs CL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BIOPX vs SCHD BIOPX vs JEPI BIOPX vs O BIOPX vs KO BIOPX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.